RA Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-418	Closed	-$5K	–	82
2022 Q3	$5K	Buy	+418	New	+$5K	﹤0.01%	81
2016 Q4	–	Sell	-13,445	Closed	-$2.16M	–	33
2016 Q3	$2.16M	Sell	13,445 -7,417	-36%	-$1.19M	0.22%	28
2016 Q2	$2.54M	Buy	+20,862	New	+$2.54M	0.35%	28